Page 43 - Robert Kramer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shake-Up at Covid Vaccine Manufacturer That Tossed Millions of Doses Emergent BioSolutions’ C.E.O. announced several executive changes but vigorously defended the company, which is on track for record revenues. Production was halted this month at the Emergent plant in Baltimore where up to 15 million doses of Johnson & Johnson vaccine had to be scrapped.Credit...Saul Loeb/Agence France-Presse — Getty Images April 29, 2021 WASHINGTON — Executives of Emergent BioSolutions, the Covid-19 vaccine manufacturer that was forced to discard up to 15 million doses because of possible contamination...

ABC News Turn on desktop notifications for breaking stories about interest? OffOn Emergent's spotty track record: What years of inspection reports show about firm tasked with helping make vaccine Inspection reports obtained by ABC News show a series of quality control issues. • 11 min read Johnson & Johnson manufacturer’s embattled history with the FDA ABC News’ Bob Woodruff examines the history of citations for Emergent Biosolutions, which was forced to pause new production of a key ingredient for Johnson & Johnson’s COVID vaccine.Dirk Waem/BELGA/AFP via Getty Images Even as shots o...

Emergent BioSolutions Inc (EBS) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Emergent BioSolutions Inc (NYSE: EBS) Popular Searches Operator Thank you for standing by, and welcome to the Emergent BioSolutions First Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to Bob Burrows. Please go ahead.SPONSORED: 10 stocks we like better than Emergent BioSolutions When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. A...

Dive Brief: Robert Kramer, the chief executive of embattled contract drug manufacturer Emergent Biosolutions, said Thursday he takes full responsibility for the error at his company's Baltimore plant that ruined millions of doses of Johnson & Johnson's coronavirus vaccine.  But the CEO pushed back against what he called "unfair criticism" of Emergent, describing the vaccine manufacturing task the company took on as "Herculean." Working with the U.S. government, Emergent had agreed to produce the drug substance for J&J's vaccine as well as one from AstraZeneca at the Baltimore site, known as ...

'); b.push("");for(var c=0;c "),b.push(a[c]),b.push(""+"script".toString()+">");b.push("");b.push("